studies like these are ongoing and do not offer conclusive evidence of the peptides potential mechanism of action
Disclosures: Volney Spalding: Nothing to Disclose, Shadi Salloum: Nothing to Disclose, Raymond Chung: Nothing to Disclose, Brian Fellenstein: Nothing to Disclose, Min Xu: Nothing to Disclose, Charlotte Warner: Nothing to Disclose, Nadia Alatrakchi: Nothing to Disclose, Wenyu Lin: Nothing to Disclose 164 THE PREVALENCE AND CLINICAL CHARACTERISTICS OF CONCURRENT HEPATITIS D INFECTION IN CHRONIC HEPATITIS B PATIENTS IN XINJIANG REGION: A MULTICENTER, RETROSPECTIVE, CROSS-SECTIONAL STUDY WEI SUN 1 Zhuanguo Wang 2 , 1 The Fourth Clinical Medical College of Xinjiang Medical University, Urumqi, China, 2 Department of Hepatology, Hospital of Traditional Chinese Medicine of Xinjiang Autonomous Region Background: This study aimed to investigate the prevalence and clinical characteristics of concurrent hepatitis D virus (HDV) infection in patients with chronic hepatitis B in the Xinjiang region
Most scientific studies available for these unregulated peptides are preclinicalin vitro or animal studieswith little or no clinical trial data
10.1039/d1ra08320a RSC Adv
